13 citations
,
April 2018 in “Journal of The American Academy of Dermatology” People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.
2 citations
,
February 2001 in “PubMed” In Switzerland, 43% of men experience hair loss, and many switch to Propecia for treatment.
November 2023 in “International Journal of Medical Sciences” New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.
9 citations
,
October 2015 in “PubMed” Acne in adult women is common and requires thorough evaluation and treatment due to its impact on self-esteem.
January 2019 in “AYBU AVESIS” Increased oxidative stress and decreased antioxidants contribute to hair loss in androgenetic alopecia.
5 citations
,
May 2020 in “Journal of the American Academy of Dermatology” AGA might indicate higher risk for severe COVID-19.
March 2005 in “Journal of The American Academy of Dermatology” Two cosmetic lotions used day and night may be a good alternative to minoxidil for hair loss treatment with better cosmetic effects and tolerance.
12 citations
,
July 2019 in “The Aging Male” Men in the U.S. have more health issues, higher death rates from various diseases, lower life expectancy, and are less likely to seek healthcare.
30 citations
,
January 2008 in “Dermatologic Surgery” Dermatologists perform most outpatient cosmetic procedures in the U.S., especially on white women aged 40 to 59.
22 citations
,
December 2007 in “Dermatologic Surgery” Dermatologists performed the most outpatient cosmetic procedures in the U.S. from 1995 to 2003, especially on white women aged 40 to 59.
Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.
2 citations
,
November 2025 in “Nutrition Journal” Probiotic supplements may help reduce inflammation and oxidative stress in women with PCOS.
1 citations
,
January 1998 in “Journal of Investigative Dermatology” Male pattern hair loss affects about one-third of men aged 18-49 years in the United States.
5 citations
,
August 1987 in “Andrology” Men with low or no sperm count have lower salivary testosterone levels, and saliva testing can measure their testosterone well.
40 citations
,
March 1982 in “British Journal of Dermatology” Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.
3 citations
,
June 2024 in “Journal of Neuroendocrinology” Many women with PCOS have abnormal cholesterol levels, needing careful management.
1 citations
,
April 2015 in “Munich Personal RePEc Archive (Ludwig Maximilian University of Munich)” Skin and hair aging involves mitochondrial issues, telomere shortening, and hormonal changes, with iron affecting hair loss in pre-menopausal women.
Balding in men worsens with age.
35 citations
,
January 2014 in “BioMed Research International” Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.
27 citations
,
May 1976 in “PubMed” Ovarian wedge resection helped regulate menstrual cycles but didn't significantly change hormone levels or hair growth in polycystic ovary syndrome.
Early treatment is important for better hair regrowth in elderly women with hair loss.
June 2026 in “Mendeley Data” The "Hair Loss Therapeutics Drug Database" is a comprehensive resource detailing pharmacological agents for treating hair loss disorders such as androgenetic alopecia, alopecia areata, and pseudofolliculitis barbae. It includes information on each drug's chemical properties, pharmacological classification, mechanism of action, molecular target, pharmacokinetics, clinical efficacy, dosage regimens, safety profile, regulatory status, and therapeutic uses. The database is designed to aid food and drug companies in research, drug development, bioinformatics, QSAR modeling, clinical decision support, and education.
June 2026 in “Mendeley Data” The "Hair Loss Therapeutics Drug Database" is a comprehensive resource detailing pharmacological agents for treating hair loss disorders such as androgenetic alopecia, alopecia areata, and pseudofolliculitis barbae. It includes information on each drug's chemical properties, pharmacological classification, mechanism of action, molecular target, pharmacokinetics, clinical efficacy, dosage regimens, safety profile, regulatory status, and therapeutic uses. The database is designed to aid food and drug companies in research, drug development, bioinformatics, QSAR modeling, clinical decision support, and education.
Patient history is key in diagnosing hair loss types.
January 2014 in “The Journal of Dermatology” Korean adolescents with androgenetic alopecia often have a family history, milder symptoms than adults, and normal hormone levels.
1 citations
,
December 2010 in “Elsevier eBooks” Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.
57 citations
,
January 1995 in “The American journal of medicine” Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.
September 2008 in “Fertility and Sterility” Exposure to fatty acids significantly increased androgen levels in female dogs, suggesting a link to conditions like insulin resistance and PCOS.
16 citations
,
April 2012 in “Gynecological Endocrinology” Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.
September 2008 in “Fertility and Sterility” Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.